Clinical guidance structured for every treatment phase

An oncology diagnosis triggers a deluge of complex documents: histology summaries, immunohistochemistry receptor assays, flow cytometry reports, and radiological findings across CT, MRI, and PET platforms. Most clinical encounters in regional hospital systems leave patients with partial answers because standard appointment intervals do not accommodate a line-by-line review.

Our Initial Diagnostic & Pathology Consultation provides an unhurried 55-minute forensic audit of your clinical records. Dr. Ivan Petrov analyzes tumor dimensions, nodal status, histologic differentiation grade, and surgical margin clearance. We cross-reference staging against current American Joint Committee on Cancer (AJCC) criteria and explain what each variable indicates for systemic recurrence risk and local disease control.

Crucially, we verify diagnostic completeness. If critical molecular biomarker panels (such as EGFR, ALK, KRAS, BRAF, MSI, or PD-L1 expression) have not been run on your biopsy tissue, we flag those omissions before irreversible treatment paths are initiated.

Cancer pharmacotherapy has transformed from empirical cytotoxic infusions into sophisticated multi-agent regimens combining alkylating agents, antimetabolites, checkpoint inhibitors, and monoclonal antibodies. Hospital infusion centers often hand patients brief drug brochures that fail to explain how drugs interact, when nadir intervals occur, or how premedications prevent acute hypersensitivity.

In our Systemic Regimen Navigation consultations, Dr. Petrov explains the specific mechanism of action for every drug in your cycle. We map your treatment calendar into a concrete schedule: day-by-day infusion timings, intravenous premedications (dexamethasone, 5-HT3 antagonists, NK1 receptor antagonists), and required hydration volumes.

We establish clear toxicity management rules. You learn the precise distinction between predictable, low-grade toxicities (mild nausea, alopecia, alteration in bowel habits) and acute oncological emergencies requiring urgent clinical intervention, such as fever with neutropenia (temperature ≥ 100.4°F), severe mucositis preventing hydration, or peripheral neuropathy progression.

Oncology care delivery is inherently fragmented. A standard course of cancer treatment demands synchronous input from surgical oncologists, medical oncologists, radiation oncologists, interventional radiologists, primary care physicians, and specialty clinical pharmacists. Gaps in records transfer often delay cycle starts or result in duplicated imaging.

Through our Multidisciplinary Care & Lab Coordination service, Zelguora acts as your central clinical anchor. We consolidate and index records across separate hospital systems into a unified medical chart. We verify that restorative surgical healing is confirmed before systemic anti-VEGF therapies begin, confirm that baseline cardiac ejections are documented prior to anthracycline dosing, and monitor weekly laboratory trends.

We also conduct proactive pharmacotherapy audits. When antineoplastic agents interact with everyday prescriptions for cardiovascular health, glycaemic management, or anticoagulation, Dr. Petrov communicates directly with prescribing providers to adjust administration timing and prevent metabolic toxicities.

Seeking an independent second opinion is an established standard of sound oncological care. Treatment guidelines evolve continuously as clinical trial outcomes emerge, and different hospital systems may favor institutional protocols over emerging molecularly targeted strategies or dose-dense schedules.

At Zelguora, our Second Opinion Protocol Audit offers an entirely independent evaluation. Because we do not sell chemotherapy drug administration or surgical interventions, Dr. Petrov evaluates your planned regimen with clinical objectivity, strictly benchmarking your pathology against National Comprehensive Cancer Network (NCCN) evidence categories and current peer-reviewed literature.

We evaluate whether standard dose calculations reflect your current renal clearance and hepatic function, whether an organ-preserving approach is feasible, or whether clinical trials offer appropriate options for your specific genetic profile. You receive a comprehensive written clinical memorandum delivered within 48 hours to share with your treating medical team.

In oncology, unexpected medical bills cause significant distress. Zelguora operates with transparent fee schedules. As an independent consultation and navigation practice, our fees depend directly on four objective clinical factors: